Satsuma Pharmaceuticals, Inc.
Total Trades
5
Buys
4
Sells
1
Largest Trade
$1M+
Insiders
4
Institutional Funds
2
Inst. Value
$100K–$500K
Activist Filings
14
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| TAKANASHI KEN | Director | BUY | $1M+ | 22.1M | $0.91 | Jun 8, 2023 |
| Shin Nippon Biomedical Laboratories, Ltd. | 10% Owner | BUY | $1M+ | 30.5M | $0.91 | Jun 8, 2023 |
| Leonard Braden Michael | 10% Owner | BUY | $100K–$500K | 150K | $0.71 | Nov 23, 2022 |
| Leonard Braden Michael | 10% Owner | BUY | $1M+ | 6.4M | $0.68 | Nov 16, 2022 |
| COMMODORE CAPITAL LP | 10% Owner | SELL | $1M+ | 3.3M | $0.71 | Nov 16, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2022 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 62K | $100K–$500K | SH |
| BNP PARIBAS FINANCIAL MARKETS | 59 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jun 12, 2023
0.0%
0 shares
SC 13D/A · Jun 12, 2023
0.0%
0 shares
Shin Nippon Biomedical Laboratories, Ltd.
SC 13D/A · Jun 8, 2023
100.0%
1K shares
SC 13D/A · Apr 18, 2023
17.9%
5.9M shares
Shin Nippon Biomedical Laboratories, Ltd.
SC 13D/A · Apr 17, 2023
8.4%
2.8M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 10, 2023
0.0%
0 shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Jan 27, 2023
7.5%
2.5M shares
SC 13G · Nov 16, 2022
19.4%
6.4M shares
SC 13G/A · Nov 16, 2022
0.0%
0 shares
SC 13G/A · Feb 25, 2022
8.2%
2.6M shares
SC 13G/A · Feb 14, 2022
11.8%
3.7M shares
SC 13G · Feb 14, 2022
5.6%
1.8M shares
SC 13G/A · Feb 11, 2022
6.0%
1.9M shares